Tech Company Financing Transactions
Yosemite Funding Round
Yosemite, based in San Francisco, received $18 million from private investors.
Transaction Overview
Company Name
Announced On
2/12/2026
Transaction Type
Debt
Amount
$18,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This support allowed us to pursue a high-risk, high-reward direction that would have been difficult to fund otherwise.
Company Information
Company Status
Private & Independent
Industry
FinTech
Mailing Address
901 Battery St
San Francisco, CA 94111
USA
San Francisco, CA 94111
USA
Phone
Undisclosed
Website
Email Address
Overview
Yosemite is an oncology-focused venture fund investing in biotech and healthcare innovations to make cancer non-lethal. Founded by Reed Jobs in 2015, the fund originated with Emerson Collective before becoming independent in 2023. Yosemite's unique investment model restructures the traditional academic-industry partnership by utilizing philanthropic capital to seed pioneering scientific research, enabling Yosemite to strengthen collaborations with academic institutions and provide access to investable science earlier in the commercialization pipeline.
Management Team
Browse more venture capital transactions:
Prev: 2/12/2026: Neurent Medical venture capital transaction
Next: 2/12/2026: BioReact venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








